Charles Schwab’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.6M Buy
1,403,948
+110,118
+9% +$5.98M 0.01% 840
2025
Q4
$59.7M Buy
1,293,830
+423
+0% +$18.9K 0.01% 1039
2025
Q3
$46.6M Sell
1,293,407
-124,304
-9% -$4.12M 0.01% 1200
2025
Q2
$46.1M Buy
1,417,711
+84,329
+6% +$2.76M 0.01% 1155
2025
Q1
$50.3M Sell
1,333,382
-8,391
-0.6% -$671K 0.01% 1064
2024
Q4
$110M Buy
1,341,773
+45,936
+4% +$4.56M 0.02% 611
2024
Q3
$148M Buy
1,295,837
+419,600
+48% +$37.8M 0.03% 470
2024
Q2
$66.2M Buy
876,237
+42,619
+5% +$2.9M 0.01% 863
2024
Q1
$56.9M Buy
833,618
+103,180
+14% +$7.14M 0.01% 944
2023
Q4
$45.9M Buy
730,438
+17,570
+2% +$913K 0.01% 1035
2023
Q3
$36.3M Buy
712,868
+104,398
+17% +$5.15M 0.01% 1112
2023
Q2
$30.4M Buy
608,470
+120,837
+25% +$5.73M 0.01% 1203
2023
Q1
$18.3M Sell
487,633
-846
-0.2% -$35.9K 0.01% 1542
2022
Q4
$23.4M Buy
488,479
+143,253
+41% +$5.62M 0.01% 1327
2022
Q3
$8.29M Buy
345,226
+55,579
+19% +$1.41M ﹤0.01% 1948
2022
Q2
$6.3M Buy
289,647
+27,356
+10% +$633K ﹤0.01% 2086
2022
Q1
$6.33M Buy
262,291
+19,972
+8% +$436K ﹤0.01% 2168
2021
Q4
$5.76M Buy
242,319
+4,571
+2% +$106K ﹤0.01% 2279
2021
Q3
$6.03M Buy
237,748
+65,145
+38% +$1.58M ﹤0.01% 2283
2021
Q2
$3.89M Buy
172,603
+36,425
+27% +$746K ﹤0.01% 2471
2021
Q1
$2.69M Buy
136,178
+18,585
+16% +$468K ﹤0.01% 2575
2020
Q4
$3.13M Buy
117,593
+1,528
+1% +$56.8K ﹤0.01% 2450
2020
Q3
$5.73M Buy
+116,065
New +$4.62M ﹤0.01% 1998

Other funds holding PCVX